New two-year data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration
In the TENAYA and LUCERNE studies, more than 60% of Vabysmo patients could be treated every four months at two years. This represents an increase from 45% at year one Patients treated with Vabysmo received a median number of 10 injections over the two years versus 15 injections for those treated with aflibercept, potentially decreasing […]
Union Health Minister Dr Mansukh Mandaviya interacts with State Health Ministers; reviews status and progress under “HarGharDastak 2.0”
“COVID is not over yet. There are reports of rising cases of COVID in some states. It is important at this time to be alert and not forget COVID Appropriate behaviour (CAB) such as wearing masks and maintaining physical distance to prevent spread of the infection”. This was stressed by Union Minister for Health and […]
FDA grants Priority Review to Roche’s Lunsumio for people with relapsed or refractory follicular lymphoma
Lunsumio® (mosunetuzumab) could be the first CD20xCD3 T-cell engaging bispecific antibody approved by the FDA for the treatment of any type of non-Hodgkin lymphoma Application is based on results from the pivotal phase I/II study showing Lunsumio induced high and durable complete response rates in people with follicular lymphoma who received two or more prior […]
WHO advises against use of two drugs for non-severe covid-19
Current evidence does not justify using colchicine to treat non-severe illness, and fluvoxamine shouldn’t be used outside of clinical trials The antidepressant drug fluvoxamine and the gout drug colchicine are not recommended for patients with mild or moderate covid-19 because there is currently insufficient evidence that they improve important outcomes for patients, and both drugs […]
New data from phase III HAVEN 6 study reinforce favourable safety and efficacy profile of Roche’s Hemlibra in people with moderate or mild haemophilia A
Hemlibra continues to demonstrate clinically meaningful bleed control, with 66.7% of participants with moderate or mild haemophilia A experiencing zero treated bleeds at 55.6 weeks median follow-up New data also reinforce Hemlibra’s favourable safety profile, with no new safety signals observed There is limited information and treatment guidance on moderate and mild haemophilia A, which […]
Roche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting
Long-term data at the European Hematology Association (EHA) 2022 congress expands understanding of the impact of Roche medicines in early-stage blood cancers with the goal of providing patients with robust and durable outcomes from their first treatment Updated data from phase III CLL14 study of Venclexta®/Venclyxto® (venetoclax) plus Gazyva®/Gazyvaro® (obinutuzumab) showed more than 60% of […]
UN Report: Global hunger numbers rose to as many as 828 million in 2021
The latest State of Food Security and Nutrition report shows the world is moving backwards in efforts to eliminate hunger and malnutrition Rome/New York -- The number of people affected by hunger globally rose to as many as 828 million in 2021, an increase of about 46 million since 2020 and 150 million since the […]
The Democratic Republic of the Congo declares 14th Ebola outbreak over
The Democratic Republic of the Congo today declared the end of the Ebola outbreak that erupted less than three months ago in Mbandaka, the capital of Equateur Province in the northwest. It was the third outbreak in the province since 2018 and the country’s 14th overall. With greater experience in Ebola control, national emergency teams, […]
WHO Director-General welcomes ACT-Accelerator fair share contributions from Norway and Sweden
WHO Director-General Dr Tedros Adhanom Ghebreyesus has welcomed contributions from Norway and Sweden to the ACT-Accelerator, which have taken both countries over their ‘fair share’ allocation. Contributions of US$ 340 million from Norway and US$ 300 million from Sweden will accelerate efforts to get vaccines into arms, facilitate access to new treatments and ensure health […]
Shri Mansukh Mandaviya to Pharma Industry: Time to move from ‘Volume to Value’ leadership to capture global market
“Let us move from ‘volume’ to ‘value’ leadership to capture the global pharmaceutical market. It is time to accumulate knowledge from global best practices in research, manufacturing and innovation and develop our own models focused on accelerating production to meet the domestic demand while increasing our global footprint”. Union Minister for Chemicals & Fertilizers and […]
